Enhabit, Inc. (NYSE:EHAB – Get Free Report) EVP Julie Diane Jolley sold 2,793 shares of the stock in a transaction on Monday, March 9th. The stock was sold at an average price of $13.63, for a total value of $38,068.59. Following the sale, the executive vice president owned 139,923 shares in the company, valued at $1,907,150.49. The trade was a 1.96% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Enhabit Stock Performance
Enhabit stock opened at $13.61 on Friday. The stock has a 50-day simple moving average of $11.57 and a 200 day simple moving average of $9.56. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.76. Enhabit, Inc. has a 12-month low of $6.47 and a 12-month high of $13.68. The stock has a market capitalization of $690.50 million, a price-to-earnings ratio of -151.27 and a beta of 1.56.
Enhabit (NYSE:EHAB – Get Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.14. The business had revenue of $270.40 million for the quarter, compared to the consensus estimate of $270.56 million. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. On average, research analysts anticipate that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Enhabit
Analysts Set New Price Targets
Several research firms have recently commented on EHAB. Truist Financial set a $13.80 price target on shares of Enhabit in a research note on Monday, February 23rd. UBS Group reaffirmed a “neutral” rating and set a $13.80 price objective (up from $12.00) on shares of Enhabit in a report on Tuesday, February 24th. Citigroup reiterated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Leerink Partners lifted their target price on Enhabit from $9.50 to $13.80 and gave the company a “market perform” rating in a research note on Monday, February 23rd. Finally, TD Cowen restated a “hold” rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a research report on Friday, March 6th. Two research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $13.57.
Get Our Latest Stock Analysis on EHAB
About Enhabit
Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.
The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.
Featured Stories
- Five stocks we like better than Enhabit
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Iran isn’t the real war
- This coin has everything going for it
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.
